Novel Targetable BIOmarkers in ANorexia NervosA (BIOANNA)
Novel Targetable BIOmarkers in ANorexia NervosA - BIOANNA
Sponsor: University Hospital, Basel, Switzerland
This observational or N/A phase trial investigates Anorexia Nervosa and Anorexia Nervosa Restricting Type and is currently actively recruiting participants. University Hospital, Basel, Switzerland leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Jan 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Jul 2023 — Dec 2023 [monthly]
Recruiting
First recorded
May 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Basel, Switzerland
- University of Zurich
For direct contact, visit the study record on ClinicalTrials.gov .